GAMMA Investing LLC Boosts Holdings in Fresenius Medical Care AG (NYSE:FMS)

GAMMA Investing LLC increased its position in Fresenius Medical Care AG (NYSE:FMSFree Report) by 43.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 7,164 shares of the company’s stock after buying an additional 2,166 shares during the period. GAMMA Investing LLC’s holdings in Fresenius Medical Care were worth $162,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in the business. Allworth Financial LP raised its position in shares of Fresenius Medical Care by 53.1% in the 3rd quarter. Allworth Financial LP now owns 1,675 shares of the company’s stock worth $36,000 after buying an additional 581 shares during the period. Mercer Global Advisors Inc. ADV boosted its position in Fresenius Medical Care by 4.5% in the 2nd quarter. Mercer Global Advisors Inc. ADV now owns 14,581 shares of the company’s stock valued at $278,000 after buying an additional 624 shares during the last quarter. MML Investors Services LLC boosted its holdings in Fresenius Medical Care by 5.3% in the third quarter. MML Investors Services LLC now owns 15,019 shares of the company’s stock valued at $320,000 after purchasing an additional 753 shares during the last quarter. Rhumbline Advisers increased its stake in shares of Fresenius Medical Care by 6.7% in the second quarter. Rhumbline Advisers now owns 18,067 shares of the company’s stock worth $345,000 after buying an additional 1,128 shares during the last quarter. Finally, Marshall Wace LLP increased its holdings in Fresenius Medical Care by 8.5% in the second quarter. Marshall Wace LLP now owns 15,363 shares of the company’s stock valued at $293,000 after buying an additional 1,207 shares during the last quarter. 8.37% of the stock is currently owned by institutional investors and hedge funds.

Fresenius Medical Care Trading Down 1.2 %

Shares of NYSE:FMS opened at $22.40 on Thursday. The stock has a market capitalization of $13.14 billion, a PE ratio of 18.51, a P/E/G ratio of 0.95 and a beta of 0.92. The firm has a fifty day moving average price of $22.39 and a 200 day moving average price of $20.73. Fresenius Medical Care AG has a 1 year low of $17.93 and a 1 year high of $24.31. The company has a current ratio of 1.37, a quick ratio of 1.02 and a debt-to-equity ratio of 0.42.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on FMS shares. StockNews.com initiated coverage on shares of Fresenius Medical Care in a research note on Friday, January 3rd. They set a “strong-buy” rating on the stock. Truist Financial upped their price objective on shares of Fresenius Medical Care from $23.00 to $25.00 and gave the stock a “hold” rating in a report on Monday. Berenberg Bank started coverage on Fresenius Medical Care in a research note on Wednesday, November 6th. They set a “buy” rating and a $25.60 price target for the company. Finally, Bank of America raised shares of Fresenius Medical Care from an “underperform” rating to a “neutral” rating in a research note on Monday, December 2nd.

View Our Latest Analysis on Fresenius Medical Care

About Fresenius Medical Care

(Free Report)

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.

Read More

Want to see what other hedge funds are holding FMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Fresenius Medical Care AG (NYSE:FMSFree Report).

Institutional Ownership by Quarter for Fresenius Medical Care (NYSE:FMS)

Receive News & Ratings for Fresenius Medical Care Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care and related companies with MarketBeat.com's FREE daily email newsletter.